Comorbidities and Health Care Services Utilisation Among Long-term Breast Cancer Survivors

NCT03846999 | Completed

• 1 other identifier: SURBCAN Project
• Study Type: observational
• Target: 21,639
• Locations: 0 countries
• Sites: N/A

Brief Summary

The increased likelihood of survival can be explained by numerous factors, such as improvements in breast cancer screening and advances in diagnosis and treatment and aging. This phenomenon is associated with comorbidity due to cancer treatment and external factors like aging or lifestyle. Little is known about how these women follow-up their disease, their pattern of use of health resources and their met and unmet needs. Studying the health needs of these women is a cancer-related priority for Cancer Organizations.The project is aimed at: 1) Describing the comorbidities and patterns of use of primary and specialized care in women who have survived a breast cancer for at least five years; 2) Comparing the comorbidities and patterns of use of long time breast cancer survivors with women without a cancer diagnosis; and 3) Estimating the use of resources in long time survivors of breast cancer adjusted for survival-time and comorbidities.

Conditions

Breast Cancer

Keywords

breast cancer; comorbidities; healthcare services research; survival

Outcome Measures

Primary Outcomes (3)

• Frequency of comorbidities

  Number of comorbidities of each woman at five-year survival from breast cancer. Assessed through ICD10.

  5 years of survival

• Frequency of visits to healthcare services

  Number of visits to primary care attention or specialised attention done by each women at five-year survival from breast cancer.

  5 years of survival

• Main health provider visited

  Leading provider of health services (GP, oncologist, community nurse, oncology nurse, physiotherapist...) of each women at five-year survival from breast cancer.

  5 years of survival

Secondary Outcomes (3)

• Frequency of visits to primary care attention

  at 5 years of survival

• Frequency of visits to specialized care attention

  at 5 years of survival

• Annual mammogram frequency

  1 year

Study Arms (2)

Long-term breast cancer survivors

Analyze comorbidities and patterns of use of health services. Describe the specific use of health services in primary care vs. specialized care. Analyze comorbidities and patterns of use of health services by tumor characteristics.

Women without history of cancer

Analyze comorbidities and patterns of use of health services. Describe the specific use of health services in primary care vs. specialized care.

Eligibility Criteria

• Age: 18 Years+
• Gender Eligibility Details: Long-term breast cancer survivors (women who survived at least 5 years from the diagnosis)
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Women with a diagnosis of breast cancer (during 2000 until 2006) with a survival period of ≥ 5 years that had a visit with the healthcare services during the period from 2012 to 2016 were identified, as well as those women without a cancer diagnosis and matched by age and area with breast cancer survivors.

You may qualify if:

• \>18 years old
• Women diagnosed with an incident breast cancer during the period from 01/01/2000 until 31/12/2006 who survived for at least 5 years.
• Women who visited at least once the primary health services during follow-up period (01/01/2012 to 31/12/2016).

You may not qualify if:

• \- Unknown diagnostic year

Sponsors & Collaborators

• Parc de Salut Mar: lead
• Fondo de Investigacion Sanitaria: collaborator
• European Regional Development Fund: collaborator
• Red de Investigación en Servicios de Salud en Enfermedades Crónicas: collaborator

Related Publications (1)

• Jansana A, Del Cura I, Prados-Torres A, Sanz Cuesta T, Poblador-Plou B, Gimeno Miguel A, Lanzuela M, Ibanez B, Tamayo I, Moreno-Iribas C, Padilla-Ruiz M, Redondo M, Comas M, Domingo L, Diaz-Holgado A, Salamanca FJ, Castells X, Sala M; SURBCAN group. Use of real-world data to study health services utilisation and comorbidities in long-term breast cancer survivors (the SURBCAN study): study protocol for a longitudinal population-based cohort study. BMJ Open. 2020 Sep 9;10(9):e040253. doi: 10.1136/bmjopen-2020-040253.

  PMID: 32912957 DERIVED

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Head of Evaluation and Quality, MD, PhD

Study Record Dates

• First Submitted: February 13, 2019
• First Posted: February 20, 2019
• Study Start: January 1, 2012
• Primary Completion: January 1, 2012
• Study Completion: December 31, 2016
• Last Updated: February 20, 2019

Record last verified: 2019-02